Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Immune Design
Immune Design
Merck to buy immunotherapy developer Immune Design for $300 million
Merck to buy immunotherapy developer Immune Design for $300 million
Reuters
Merck
Immune Design
M&A
immunotherapy
Flag link:
Immune Design buries its PhIII work on cancer, and investors hit the panic button
Immune Design buries its PhIII work on cancer, and investors hit the panic button
Endpoints
Immune Design
CMB305
Flag link:
Immune Design Poised on Progress of Pipeline Candidates
Immune Design Poised on Progress of Pipeline Candidates
Yahoo/Zacks.com
Immune Design
CMB305
soft tissue sarcoma
G100
Flag link:
Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma
Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma
Yahoo
Keytruda
Immune Design
Merck
clinical trials
melanoma
non-Hodgkin's lymphoma
LV305
G100
Flag link:
7 Biotech Stocks Moving Off The UBS Healthcare Conference
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
Flag link:
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy
Yahoo
Sanofi Pasteur
Immune Design
herpes simplex virus
R&D
Flag link:
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy
Yahoo
GLAAS plantform
Immune Design
Sanofi
food allergies
Flag link:
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Seeking Alpha
Teva Pharmaceuticals
Sanofi
Pfizer
Pacific Biosciences
Merck
Macrogenics
Hikma
GSK
BMP Sunstone
biotech
Baxter International
Amicus Therapeutics
Immune Design
MedImmune
Flag link: